Synopsis
Synopsis
0
API Suppliers
0
USDMF
0
CEP/COS
0
JDMF
0
EU WC
0
KDMF
0
NDC API
0
VMF
0
Listed Suppliers
0
API
0
FDF
0
FDF Dossiers
0
FDA Orange Book
0
Europe
0
Canada
0
Australia
0
South Africa
0
Listed Dossiers
DRUG PRODUCT COMPOSITIONS
0
EDQM
0
USP
0
JP
0
Others
0
US Patents
0
US Exclusivities
0
Health Canada Patents
0
Data Compilation #PharmaFlow
0
Stock Recap #PipelineProspector
0
Weekly News Recap #Phispers
0
News #PharmaBuzz
US Medicaid
NA
Annual Reports
NA
Finished Drug Prices
NA
1. 3416-57-7
2. N-acetonylphthalimide
3. 2-(2-oxopropyl)isoindoline-1,3-dione
4. 2-(2-oxopropyl)-1h-isoindole-1,3(2h)-dione
5. 2-(2-oxopropyl)isoindole-1,3-dione
6. 1-(n-phthalimidyl)-2-propanone
7. 1h-isoindole-1,3(2h)-dione, 2-(2-oxopropyl)-
8. Mfcd00088346
9. Nsc-35996
10. N-(2-oxopropyl)phthalimide
11. C4zc7v7nj6
12. 2-(2-oxo-propyl)-isoindole-1,3-dione
13. Nsc35996
14. Phthalimide, N-acetonyl-
15. Unii-c4zc7v7nj6
16. Schembl624540
17. Chembl315571
18. 2-acetonylisoindoline-1,3-dione
19. Stmrglkpbjvveg-uhfffaoysa-
20. Zinc36650
21. Dtxsid40284160
22. Albb-012938
23. Amy30178
24. Stl257200
25. Akos001074246
26. Ab03244
27. Cs-w015465
28. 5(6)-carboxyfluoresceindiacetate
29. Sy051184
30. Db-048576
31. Bb 0258825
32. Ft-0634846
33. Benzo[c]pyrrolidin-2,5-dione, N-acetylmethyl-
34. 3w-0868
35. A822106
36. Ae-641/00649058
37. 2-(2-oxopropyl)-1h-isoindole-1,3(2h)-dione #
38. F3308-2937
39. 2-(2-oxopropyl)-2,3-dihydro-1h-isoindole-1,3-dione
| Molecular Weight | 203.19 g/mol |
|---|---|
| Molecular Formula | C11H9NO3 |
| XLogP3 | 1.1 |
| Hydrogen Bond Donor Count | 0 |
| Hydrogen Bond Acceptor Count | 3 |
| Rotatable Bond Count | 2 |
| Exact Mass | 203.058243149 g/mol |
| Monoisotopic Mass | 203.058243149 g/mol |
| Topological Polar Surface Area | 54.4 Ų |
| Heavy Atom Count | 15 |
| Formal Charge | 0 |
| Complexity | 300 |
| Isotope Atom Count | 0 |
| Defined Atom Stereocenter Count | 0 |
| Undefined Atom Stereocenter Count | 0 |
| Defined Bond Stereocenter Count | 0 |
| Undefined Bond Stereocenter Count | 0 |
| Covalently Bonded Unit Count | 1 |
ABOUT THIS PAGE
A Phthalimidoacetone manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Phthalimidoacetone, including repackagers and relabelers. The FDA regulates Phthalimidoacetone manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Phthalimidoacetone API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.
A Phthalimidoacetone supplier is an individual or a company that provides Phthalimidoacetone active pharmaceutical ingredient (API) or Phthalimidoacetone finished formulations upon request. The Phthalimidoacetone suppliers may include Phthalimidoacetone API manufacturers, exporters, distributors and traders.
Phthalimidoacetone Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.
GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).
PharmaCompass offers a list of Phthalimidoacetone GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Phthalimidoacetone GMP manufacturer or Phthalimidoacetone GMP API supplier for your needs.
A Phthalimidoacetone CoA (Certificate of Analysis) is a formal document that attests to Phthalimidoacetone's compliance with Phthalimidoacetone specifications and serves as a tool for batch-level quality control.
Phthalimidoacetone CoA mostly includes findings from lab analyses of a specific batch. For each Phthalimidoacetone CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.
Phthalimidoacetone may be tested according to a variety of international standards, such as European Pharmacopoeia (Phthalimidoacetone EP), Phthalimidoacetone JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Phthalimidoacetone USP).
LOOKING FOR A SUPPLIER?
